TABLE 1.
Immunogen (immunization method) | Wk 1d
|
Wk 5
|
||
---|---|---|---|---|
ELISAb | PRNT50c | ELISAb | PRNT50c | |
L(EV) i.v. | 1,000 | <20 | 5,000 | <20 |
L(EV) i.m. | 1,000 | <20 | 5,000 | <20 |
EV i.v. | NDd | ND | 500 | <20 |
EV i.m. | ND | ND | 500 | <20 |
L i.v. | <100 | <20 | <100 | <20 |
L i.m. | <100 | <20 | <100 | <20 |
BALB/c mice were immunized i.v. or i.m. with L(EV), or EV or L and bled 1 and 5 weeks after the second immunization. Sera were pooled and analyzed for EBO-Z-specific and neutralizing antibodies (see Materials and Methods).
Data shown represent the endpoint titers for ELISA.
PRNT50 values represent reciprocal 50% endpoint dilutions for neutralizing antibodies.
ND, not determined.